Get the Stockscreener App
5.07
4.16%
-0.22
After Hours:
5.09
0.02
+0.39%
Sophia Genetics Sa stock is traded at $5.07, with a volume of 93,666.
It is down -4.16% in the last 24 hours and up +0.60% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$5.29
Open:
$4.93
24h Volume:
93,666
Relative Volume:
0.74
Market Cap:
$363.36M
Revenue:
$77.27M
Net Income/Loss:
$-79.00M
P/E Ratio:
-4.3356
EPS:
-1.1694
Net Cash Flow:
$-48.46M
1W Performance:
+1.40%
1M Performance:
+0.60%
6M Performance:
+12.17%
1Y Performance:
+61.46%
1-Day Range:
$4.92
$5.2799
1-Week Range:
$4.92
$5.60
52-Week Range:
$2.59
$5.70
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH vs VEEV, BTSG, TEM, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
5.07 | 379.13M | 77.27M | -79.00M | -48.46M | -1.1694 |
VEEV
Veeva Systems Inc
|
171.19 | 27.80B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
51.44 | 10.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
54.07 | 10.01B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.63 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.77 | 4.60B | 637.78M | 239.40M | 307.21M | 1.1909 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
SOPHiA GENETICS Earnings Call: Growth With Caveats - TipRanks
SOPHiA GENETICS S.A. Q1 2026 Earnings Call Summary - Yahoo Finance
SOPHiA GENETICS Q1 Earnings Call Highlights - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
SOPHiA GENETICS SA reports results for the quarter ended March 31Earnings Summary - TradingView
BTIG Raises its Price Target on SOPHiA GENETICS (SOPH) to $8 - Insider Monkey
SOPHiA GENETICS Posts Higher Q1 2026 Revenue but Wider Loss in Newly Filed Form 6-K - TipRanks
SOPH: Q1 2026 revenue up 22% year-over-year, with improved margins and strong global expansion - TradingView
SOPHiA GENETICS Reports First Quarter 2026 Results - PR Newswire
SOPHiA GENETICS (SOPH) grows Q1 2026 revenue 22% but remains loss-making - Stock Titan
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $24,100.00 in Stock - MarketBeat
SOPHiA GENETICS (SOPH) CMO sells 5,000 shares under 10b5-1 plan - Stock Titan
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Drops By 31.0% - MarketBeat
SOPHiA GENETICS (SOPH) Projected to Post Earnings on Tuesday - MarketBeat
SOPH Price Today: SOPHiA GENETICS SA Stock Price, Quote & Chart | MEXC - MEXC Exchange
Tangible book value per share of SOPHiA GENETICS SA – LS:A3CVT8 - TradingView
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results (PR Newswire) - Aktiellt
SOPHiA (SOPH) Industry Outlook | SOPHiA GENETICS SA misses EPS by 3.2% on $77.3M revenueProfit - Cổng thông tin điện tử tỉnh Lào Cai
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells 4,486 Shares of Stock - MarketBeat
SOPHiA GENETICS (SOPH) HR chief sells 380 shares to cover RSU taxes - Stock Titan
SOPHiA GENETICS (SOPH) CSO sells 608 shares under 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) legal chief sells 684 shares for tax withholding - Stock Titan
CEO’s tax-driven share sale at SOPHiA GENETICS (SOPH) detailed - Stock Titan
SOPHiA GENETICS (SOPH) CMO tax-related sale of 608 shares under 10b5-1 plan - Stock Titan
Tax-driven SOPHiA GENETICS (SOPH) insider sale under Rule 10b5-1 plan - Stock Titan
Tax-related sell-to-cover by SOPHiA GENETICS (SOPH) Chief Sales Officer - Stock Titan
SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026 - Finviz
Multiple 10b5-1 sales by SOPH insider (NASDAQ: SOPH) reported - Stock Titan
[144] SOPHiA GENETICS SA SEC Filing - Stock Titan
SOPH (NASDAQ: SOPH) lists 10b5-1 sales including 3,824 shares on 04/08/2026 - Stock Titan
Multiple 10b5‑1 insider sales reported at SOPH (NASDAQ: SOPH) - Stock Titan
760-share Rule 144 notice; SOPH (NASDAQ: SOPH) lists 10b5-1 trades Feb–Apr 2026 - Stock Titan
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 - Sahm
Insider Sell: Zhenyu Xu Sells Shares of Sophia Genetics SA - GuruFocus
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) President Sells 2,800 Shares of Stock - MarketBeat
Jurgi Camblong Sells 43,129 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $87,365.00 in Stock - MarketBeat
SOPHiA GENETICS (SOPH) CSO executes 600-share Rule 10b5-1 sale - Stock Titan
SOPHiA GENETICS (SOPH) CEO’s 60,602-share sale funds RSU tax withholding - Stock Titan
[Form 4] SOPHiA GENETICS SA Insider Trading Activity - Stock Titan
SOPHiA GENETICS (SOPH) president sells 2,800 shares under Rule 10b5-1 tax plan - Stock Titan
SOPH SEC FilingsSophia Genetics Sa 10-K, 10-Q, 8-K Forms - Stock Titan
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 – Company AnnouncementFT.com - Financial Times
SOPH Maintained by BTIG -- Price Target Raised to $8.00 - GuruFocus
BTIG raises Sophia Genetics stock price target on data strategy By Investing.com - Investing.com Australia
SOPHiA GENETICS (NASDAQ:SOPH) Insider Zhenyu Xu Sells 3,706 Shares - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) President Sells 3,687 Shares of Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) CEO Jurgi Camblong Sells 4,399 Shares - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $21,010.64 in Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) President Ross Muken Sells 4,442 Shares - MarketBeat
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.66%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):